The U.S. Food and Drug Administration (FDA) has granted fast track designation to UB-VV111 for the treatment of ...
Researchers have identified how to encourage tumors to build their own immune hubs—structures that look and function like ...
Professor Alexander Hoffmann and Genhong Cheng from University of California, Los Angeles, jointly with Professor David ...
The FDA has granted fast track designation to UB-VV111 for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) following 2 or more prior lines of therapy and relapsed/refractory chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback